MAI Capital Management’s Vor Biopharma VOR Stock Holding History

MAI Capital Management’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$714	Hold	40	–	–	﹤0.01%	4296
2025 Q4	$524	Hold	40	–	–	﹤0.01%	3815
2025 Q3	$1.95K	Sell	40 -143	-78%	-$5.75K	﹤0.01%	3317
2025 Q2	$5.92K	Sell	183 -14,235	-99%	-$126K	﹤0.01%	2979
2025 Q1	$207K	Buy	14,418 +258	+2%	+$6.2K	﹤0.01%	1105
2024 Q4	$314K	Sell	14,160 -9,635	-40%	-$160K	﹤0.01%	978
2024 Q3	$333K	Buy	23,795 +292	+1%	+$5.32K	﹤0.01%	843
2024 Q2	$470K	Buy	23,503 +5,210	+28%	+$169K	﹤0.01%	833
2024 Q1	$867K	Buy	18,293 +435	+2%	+$19.1K	0.01%	627
2023 Q4	$804K	Buy	+17,858	New	+$737K	0.01%	541

Other funds holding VOR

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MAI Capital Management's VOR Position: Q1 2026 in Review

MAI Capital Management held its Vor Biopharma (VOR) position steady in Q1 2026 at 40 shares worth $714. The position accounts for ﹤0.01% of the portfolio, ranked #4296.

MAI Capital Management first reported a position in VOR in Q4 2023 and has held it in 10 quarters since. The position peaked at $867K in Q1 2024. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

MAI Capital Management held 40 shares of Vor Biopharma worth $714 as of Q1 2026.
MAI Capital Management left its Vor Biopharma share count unchanged in Q1 2026.
Vor Biopharma made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4296 holding.
MAI Capital Management first reported a position in Vor Biopharma in Q4 2023 and has held it in 10 quarters since.
MAI Capital Management's Vor Biopharma position peaked at $867K in Q1 2024.
80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.